{"created":"2021-03-01T06:26:18.446164+00:00","id":21273,"links":{},"metadata":{"_buckets":{"deposit":"0564558a-9659-4f40-bc15-4a4da78ebafd"},"_deposit":{"id":"21273","owners":[],"pid":{"revision_id":0,"type":"depid","value":"21273"},"status":"published"},"_oai":{"id":"oai:niigata-u.repo.nii.ac.jp:00021273"},"item_7_alternative_title_1":{"attribute_name":"\u305d\u306e\u4ed6\u306e\u30bf\u30a4\u30c8\u30eb","attribute_value_mlt":[{"subitem_alternative_title":"Serum Levels of 2'-5' Oligoadenylate Synthetase Activities in Patients with Kawasaki Disease"}]},"item_7_biblio_info_6":{"attribute_name":"\u66f8\u8a8c\u60c5\u5831","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"1991-10","bibliographicIssueDateType":"Issued"},"bibliographicIssueNumber":"10","bibliographicPageEnd":"709","bibliographicPageStart":"707","bibliographicVolumeNumber":"105","bibliographic_titles":[{"bibliographic_title":"\u65b0\u6f5f\u533b\u5b66\u4f1a\u96d1\u8a8c"},{"bibliographic_title":"\u65b0\u6f5f\u533b\u5b66\u4f1a\u96d1\u8a8c","bibliographic_titleLang":"en"}]}]},"item_7_description_4":{"attribute_name":"\u6284\u9332","attribute_value_mlt":[{"subitem_description":"Serum levels of 2'-5' oligoadenylate (2-5A) synthetase activities have been measured in 27 patients with kawasaki disease (KD) and 20 age-matched healthy controls using 2-5A radioimmunoassay kit. All patients have been treated with aspirin 30mg/kg/day per os and intravenous \u03b3-globlin 400mg/kg/day for 5days. Blood samples were obtained on (1) acute phase (5\uff5e8 days after onset and before \u03b3-glb. therapy), (2) 5days after \u03b3-glb. therapy (10\uff5e13 days after onset), (3) 12 days and (4) 19 days after \u03b3-glb. Serum 2-5A in acute phase of KD did not increase significantly in comparison with healthy controls and any other phases of KD. This result suggests that virus infections may not be related directly to the etiology of KD.","subitem_description_type":"Abstract"}]},"item_7_full_name_3":{"attribute_name":"\u8457\u8005\u5225\u540d","attribute_value_mlt":[{"nameIdentifiers":[{"nameIdentifier":"130256","nameIdentifierScheme":"WEKO"}],"names":[{"name":"Ogawa, Naoko"}]}]},"item_7_publisher_7":{"attribute_name":"\u51fa\u7248\u8005","attribute_value_mlt":[{"subitem_publisher":"\u65b0\u6f5f\u533b\u5b66\u4f1a"}]},"item_7_select_19":{"attribute_name":"\u8457\u8005\u7248\u30d5\u30e9\u30b0","attribute_value_mlt":[{"subitem_select_item":"publisher"}]},"item_7_source_id_11":{"attribute_name":"\u66f8\u8a8c\u30ec\u30b3\u30fc\u30c9ID","attribute_value_mlt":[{"subitem_source_identifier":"AN00182415","subitem_source_identifier_type":"NCID"}]},"item_7_source_id_9":{"attribute_name":"ISSN","attribute_value_mlt":[{"subitem_source_identifier":"00290440","subitem_source_identifier_type":"ISSN"}]},"item_creator":{"attribute_name":"\u8457\u8005","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"\u5c0f\u5ddd, \u76f4\u5b50"}],"nameIdentifiers":[{"nameIdentifier":"130255","nameIdentifierScheme":"WEKO"}]}]},"item_files":{"attribute_name":"\u30d5\u30a1\u30a4\u30eb\u60c5\u5831","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_date","date":[{"dateType":"Available","dateValue":"2019-08-16"}],"displaytype":"detail","filename":"105(10)_707-709.pdf","filesize":[{"value":"567.5 kB"}],"format":"application/pdf","licensetype":"license_note","mimetype":"application/pdf","url":{"label":"105(10)_707-709.pdf","url":"https://niigata-u.repo.nii.ac.jp/record/21273/files/105(10)_707-709.pdf"},"version_id":"2d07ac40-e25c-4113-acef-a20c714a6b1d"}]},"item_keyword":{"attribute_name":"\u30ad\u30fc\u30ef\u30fc\u30c9","attribute_value_mlt":[{"subitem_subject":"Kawasaki disease","subitem_subject_scheme":"Other"},{"subitem_subject":"2'-5' oligoadenylate synthetase activity","subitem_subject_scheme":"Other"},{"subitem_subject":"virus infection","subitem_subject_scheme":"Other"},{"subitem_subject":"\u5ddd\u5d0e\u75c5","subitem_subject_scheme":"Other"},{"subitem_subject":"2'-5'\u30aa\u30ea\u30b4\u30a2\u30c7\u30cb\u30eb\u9178\u5408\u6210\u9175\u7d20\u6d3b\u6027","subitem_subject_scheme":"Other"},{"subitem_subject":"\u30a6\u30a4\u30eb\u30b9\u611f\u67d3\u75c7","subitem_subject_scheme":"Other"}]},"item_language":{"attribute_name":"\u8a00\u8a9e","attribute_value_mlt":[{"subitem_language":"jpn"}]},"item_resource_type":{"attribute_name":"\u8cc7\u6e90\u30bf\u30a4\u30d7","attribute_value_mlt":[{"resourcetype":"departmental bulletin paper","resourceuri":"http://purl.org/coar/resource_type/c_6501"}]},"item_title":"\u5ddd\u5d0e\u75c5\u306b\u304a\u3051\u308b2'-5'\u30aa\u30ea\u30b4\u30a2\u30c7\u30cb\u30eb\u9178\u5408\u6210\u9175\u7d20\u6d3b\u6027","item_titles":{"attribute_name":"\u30bf\u30a4\u30c8\u30eb","attribute_value_mlt":[{"subitem_title":"\u5ddd\u5d0e\u75c5\u306b\u304a\u3051\u308b2'-5'\u30aa\u30ea\u30b4\u30a2\u30c7\u30cb\u30eb\u9178\u5408\u6210\u9175\u7d20\u6d3b\u6027"},{"subitem_title":"\u5ddd\u5d0e\u75c5\u306b\u304a\u3051\u308b2'-5'\u30aa\u30ea\u30b4\u30a2\u30c7\u30cb\u30eb\u9178\u5408\u6210\u9175\u7d20\u6d3b\u6027","subitem_title_language":"en"}]},"item_type_id":"7","owner":"1","path":["453/456","471/537/538/1181"],"pubdate":{"attribute_name":"\u516c\u958b\u65e5","attribute_value":"2016-03-11"},"publish_date":"2016-03-11","publish_status":"0","recid":"21273","relation_version_is_last":true,"title":["\u5ddd\u5d0e\u75c5\u306b\u304a\u3051\u308b2'-5'\u30aa\u30ea\u30b4\u30a2\u30c7\u30cb\u30eb\u9178\u5408\u6210\u9175\u7d20\u6d3b\u6027"],"weko_creator_id":"1","weko_shared_id":null},"updated":"2021-03-01T13:45:35.671335+00:00"}